DaVita introduces Kidney Smart website for patients with CKD

DaVita Inc. (NYSE: DVA), a leading provider of kidney care services that is committed to improving the quality of life for those diagnosed with chronic kidney disease (CKD), today announced the launch of its Kidney SmartSM website, KidneySmart.org, for anyone with questions about CKD.    

The website offers educational information for individuals affected by CKD at no cost and is recommended for potential patients, caregivers, or anyone looking to learn more about the disease and its risk factors.

Diabetes is the number one cause of kidney failure, followed by high blood pressure. Individuals with cardiovascular disease, obesity, high cholesterol, and those over age 60 or with family history of the disease are also at risk. Other high-risk groups for kidney disease include African Americans, Hispanics, Native Americans, Pacific Islanders and Asian Americans.

"Our goal is to de-mystify kidney disease," explained Ben Harber, senior director of clinical operations for DaVita VillageHealth®. "That's why DaVita designed a website that answers the questions most patients ask when they are diagnosed with kidney disease."

Visitors to the new KidneySmart.org website can choose from the following three educational modules:

  • I am in the Early Stage of CKD
  • I am in the Late Stage of CKD
  • I am a Care Partner

The new website is part of DaVita's broader commitment to provide the superior health education experiences to patients across a number of platforms. Patients can easily access KidneySmart.org on mobile devices such as smartphones and tablets.

The KidneySmart.org website is designed to complement the in-person classes that will continue to be offered in community venues across the U.S. Currently DaVita® offers nearly 1,000 CKD education classes at no charge across the country.    

Source:

DaVita    

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Novel multi-biomarker approach enhances chronic kidney disease risk assessment